lunedì, 17 giugno 2024
21 Aprile 2017

Update to ASCO Clinical Practice Guideline on Potentially Curable Pancreatic Cancer

April 19, 2017 – An ASCO clinical practice guideline update, reported by Khorana et al in the Journal of Clinical Oncology, includes the recommendation of gemcitabine-capecitabine doublet therapy as an adjuvant therapy option in potentially curable pancreatic cancer. The updated recommendation (4.1) modifies the corresponding recommendation in the ASCO guideline published in May 2016. The remaining recommendations from the original 2016 ASCO guideline are … (leggi tutto)